Split Cas Enzyme Dimerization Screening Assay

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting molecular dimerization events in biochemistry lack high-throughput capabilities, robustness, and clear readouts, often resulting in false positives due to non-specific signal generation.

Innovation Solution

The development of dimerization screening assays using a split Cas enzyme that forms a functional ribonucleoprotein complex with both cis- and trans-cleavage activity, employing blocked nucleic acid molecules or guide RNA to prevent non-specific activation, allowing for robust and reprogrammable detection of dimerization events at attomolar limits.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional dimerization detection methods are used, then detection capability is provided, but high-throughput capability and robustness are lacking

Engineering Contradiction:
Improvehigh-throughput capabilityVSAvoidrobustness
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The Cas enzyme is divided into two separate fragments (N-terminal and C-terminal portions) that cannot function independently. Each fragment is fused to a different binding partner, and only when the binding partners dimerize do the fragments come together to form a functional enzyme. This segmentation enables high-throughput screening while maintaining robustness through specific dimerization-dependent activation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The binding partners are pre-fused to the Cas enzyme fragments before the dimerization event occurs. This preliminary configuration ensures that when dimerization happens, the functional complex is immediately assembled and activated, enabling rapid detection suitable for high-throughput applications without requiring additional assembly steps.

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If detection sensitivity is increased, then detection limit is improved, but false positives due to non-specific signal generation increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidfalse positives
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

Blocked nucleic acid molecules are introduced that prevent non-specific activation of the Cas enzyme. These blocked molecules remain inactive unless specifically unblocked by the correct target sequence, thereby preventing false positive signals while maintaining high detection sensitivity for specific targets.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

Blocked nucleic acid molecules act as intermediaries between the Cas enzyme and the target. They serve as a controlled activation mechanism that requires specific recognition to become unblocked and activate the enzyme, thereby filtering out non-specific signals while allowing specific target detection.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Difficulty of detecting and measuring

If clear readout is achieved, then detection clarity is improved, but assay complexity increases

Engineering Contradiction:
Improvereadout clarityVSAvoidassay complexity
Core Design Contradiction:
Difficulty of detecting and measuringVSDevice complexity

Solution Approach 1:

The assay utilizes fluorescent reporter molecules that emit light when activated by the Cas enzyme. This color/fluorescence change provides a clear, easily detectable readout signal that can be measured in high-throughput formats without requiring complex detection instrumentation, thus improving readout clarity while managing assay complexity.

Inventive Principle:
Principle #32Color changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The assays provide accurate and sensitive detection of putative binding pairs, minimizing false positives by ensuring the ribonucleoprotein complex is only activated upon specific dimerization events, enabling high-throughput screening with minimal non-specific signal generation.

Implementation Method 1

a first ribonucleoprotein complex (RNP1) that, when activated, exhibits cis- and trans-cleavage activity

Methodology Applied
Scientific EffectNuclease activity: Enzyme

Implementation Method 2

employing blocked nucleic acid molecules or guide RNA to prevent non-specific activation

Methodology Applied
Scientific EffectMolecular blocking:

Implementation Method 3

dimerization screening assays that detect dimerization events

Methodology Applied
Scientific EffectMolecular binding:

Data Source

PatentUS20240272172A1Dimerization screening assays
Publication Date: 2024.08.15 VEDABIO INC
  • US20240272172A1 patent drawing
  • US20240272172A1 patent drawing
  • US20240272172A1 patent drawing

AI summary

The present disclosure relates to compositions of matter and assay methods used to screen for molecular dimerization events using a two-ribonucleoprotein complex signal boost assay. The compositions and methods provide a readout upon detection of dimerization of molecules and may be implemented in a high throughput manner using libraries of tens to hundreds to thousands of putative binding partners.